Quick Answer
STRATA Skin Sciences, Inc. reported R&D Expense of $421.0 thousand for fiscal year 2025.
STRATA Skin Sciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $421.0K | -52.3% |
| 2024 | $883.0K | -33.0% |
| 2023 | $1.32M | +28.0% |
| 2022 | $1.03M | -28.2% |
| 2021 | $1.43M | +12.6% |
| 2020 | $1.27M | +27.1% |
| 2019 | $1.00M | -5.9% |
| 2018 | $1.06M | -37.8% |
| 2017 | $1.71M | -11.3% |
| 2016 | $1.93M | -4.9% |
| 2015 | $2.03M | +23.6% |
| 2014 | $1.64M | -56.6% |
| 2013 | $3.78M | -44.3% |
| 2012 | $6.79M | -29.7% |
| 2011 | $9.66M | -16.0% |
| 2010 | $11.50M | +5.0% |
| 2009 | $10.95M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $172.0K | -29.2% | +100.0% |
| June 30, 2025 | $86.0K | -56.8% | -10.4% |
| March 31, 2025 | $96.0K | -60.2% | -60.5% |
| September 30, 2024 | $243.0K | -2.0% | +22.1% |
| June 30, 2024 | $199.0K | -46.8% | -17.4% |
| March 31, 2024 | $241.0K | -23.5% | -2.8% |
| September 30, 2023 | $248.0K | +14.8% | -33.7% |
| June 30, 2023 | $374.0K | +78.9% | +18.7% |
- STRATA Skin Sciences, Inc. showed a decrease of -52.3% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, STRATA Skin Sciences, Inc.’s r&d expense has declined by 96.2% (from $10.95 million to $421.0 thousand).
- The most recent figure is from STRATA Skin Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: